866-997-4948(US-Canada Toll Free)

Dyskinesia Global Clinical Trials Review, H2, 2017

Published By :

GlobalData

Published Date : Jul 2017

Category :

Pharmaceutical

No. of Pages : 243 Pages

Dyskinesia Global Clinical Trials Review, H2, 2017

Summary

GlobalData's clinical trial report, Dyskinesia Global Clinical Trials Review, H2, 2017" provides an overview of Dyskinesia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyskinesia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Dyskinesia to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Dyskinesia to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Dyskinesia Therapeutics Clinical Trials 31
Prominent Drugs 33
Latest Clinical Trials News on Dyskinesia 34
Jun 12, 2017: Adamas Announces Publication of ADS-5102 Phase 3 EASE LID Clinical Trial in JAMA Neurology 34
Clinical Trial Profile Snapshots 35
Appendix 241
Abbreviations 241
Definitions 241
Research Methodology 242
Secondary Research 242
About GlobalData 243
Contact Us 243
Source 243

List of Tables
Dyskinesia Therapeutics, Global, Clinical Trials by Region, 2017* 7
Dyskinesia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Dyskinesia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Dyskinesia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
Dyskinesia Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Dyskinesia Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Dyskinesia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 13
Dyskinesia Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14
Proportion of Dyskinesia to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 15
Dyskinesia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Dyskinesia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Dyskinesia to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 19
Dyskinesia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Dyskinesia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Dyskinesia Therapeutics, Global, Clinical Trials by Phase, 2017* 22
Dyskinesia Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
Dyskinesia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25
Dyskinesia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26
Dyskinesia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27
Dyskinesia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 28
Dyskinesia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 30
Dyskinesia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 32
Dyskinesia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33

List of Figures
Dyskinesia Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Dyskinesia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Dyskinesia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Dyskinesia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
Dyskinesia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Dyskinesia Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Dyskinesia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 13
Dyskinesia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 14
Proportion of Dyskinesia to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 15
Dyskinesia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Dyskinesia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Dyskinesia to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 18
Dyskinesia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Dyskinesia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Dyskinesia Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
Dyskinesia Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23
Dyskinesia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Dyskinesia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26
Dyskinesia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27
Dyskinesia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 28
Dyskinesia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
Dyskinesia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31
Dyskinesia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33
GlobalData Methodology 242

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *